Despite rapid therapeutic advances in sickle cell disease, from red blood cell exchange to gene therapies, delivery remains constrained by infrastructure, geography, and care fragmentation.
Analytical performance begins long before a sample reaches the instrument, making sample preparation one of the most important determinants of data quality.